GlassScriptPhysician profile
Samuel S Murala
NPI 1205210150
$8,496.22
in general payments reported to CMS, 2019-2025
16 companies · $245 in 2025
The $245 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,606 · 2020: $139 · 2021: $949 · 2022: $1,387 · 2023: $266 · 2024: $905 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $764 · Food and Beverage: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $764.20 |
| Food and Beverage | $652.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $3,971.13 | 2019-2020 | |
| Spinal Simplicity, LLC | $1,190.47 | 2022 | |
| Boston Scientific Corporation | $1,099.24 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Medtronic, INC. | $722.17 | 2021-2023 | Synchromedii |
| Nevro Corp. | $682.84 | 2019-2022 | |
| Grt US Holding, INC. | $146.00 | 2022 | |
| Vertos Medical, INC. | $135.53 | 2019 | |
| Idorsia Pharmaceuticals US INC | $108.57 | 2023 | Quviviq |
| Curonix LLC | $97.95 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Gilead Sciences, INC. | $95.58 | 2023 | Epclusa |
| Amgen INC. | $69.07 | 2020 | |
| Stimwave Technologies Incorporated | $57.08 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $55.43 | 2019 | |
| Stryker Corporation | $33.75 | 2019 | |
| Abbott Laboratories | $16.57 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $14.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Murala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.